PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12830260::ACT034424

TXM-CB3

Evidence text

Paper-level observation

Fig. 3B: CB3 treatment improved locomotor activity, as evident by a significantly greater total distance traveled (p < 0.01).
textConfidence: medium

Assay observation

Activity
Other
Subtype
Not reported by source
Measure
other
Comparator
<
Raw observation
significantly greater total distance traveled cm
Normalized measurement
<0.01 other
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Rattus norvegicus
Assay method
Not reported by source
Sequence
ACCPCNH
Standardization
ready simple
Assay conditions
"original_unit=cm"

Source publication

Thioredoxin-mimetic peptide attenuates epilepsy progression and neurocognitive deficits

Redox Biology · 2026

DOI 10.1016/j.redox.2026.104021 PMC12830260
Parent mention

Related peptide identities

PEPDIA-PLP-000024

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.